…
Augmentum Fintech PLC is a venture capital fund specializing in seed, early to mid to late venture, series A & B investments. The firm does not invest in seed stage. The fund invests in unquoted fintech businesses which are high growth, with scalable opportunities, and have disruptive technologies in the banking, insurance and asset management sectors, including other cross-industry propositions. The fund focuses to invest in United Kingdom, Germany, France and the Nordics. The fund typically invests in firms with £4 million ($5.54 million) to £15 million ($20.80 million) equity investments. The fund prefers a significant minority stake in companies. The fund's objective is to make long term investments. The fund prefers to exit by the way of an IPO, with valuation return targets ranging from $61.46 million to in excess of $1,229.15 million.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | -15.22M | 13.80M | 4.89M | 59.31M | 19.68M |
| Net income | -15.22M | 13.80M | 4.89M | 59.31M | 19.68M |
| Selling general administrative | 2.79M | 2.69M | 5.38M | 3.88M | 2.92M |
| Gross profit | -10.25M | 18.55M | 10.27M | 63.19M | 22.59M |
| Ebit | - | 13.84M | - | - | - |
| Ebitda | -15.22M | 13.99M | 4.89M | 59.31M | 19.68M |
| Depreciation and amortization | - | 0.15M | - | - | - |
| Operating income | -15.22M | 13.80M | 4.89M | 59.31M | 19.68M |
| Other operating expenses | 5.72M | 5.48M | 5.38M | 3.88M | 2.92M |
| Interest expense | - | - | - | 4.14M | 4.14M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | 1.57M | 1.68M | 0.41M | 0.00M | 0.01M |
| Net interest income | 1.57M | 1.68M | 0.41M | 0.00M | -4.13M |
| Income tax expense | - | -0.17M | - | - | - |
| Total revenue | -9.51M | 19.28M | 10.27M | 63.19M | 22.59M |
| Total operating expenses | 5.72M | 5.48M | 5.38M | 3.88M | 2.92M |
| Cost of revenue | - | 0.73M | - | - | 0.33M |
| Total other income expense net | - | 0.73M | - | - | -4.14M |
| Net income from continuing ops | -15.22M | 13.80M | 4.89M | 59.31M | 19.68M |
| Net income applicable to common shares | - | - | - | - | 19.68M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 288.91M | 304.49M | 295.75M | 301.28M | 191.76M |
| Other current assets | - | -38.75M | - | - | 0.14M |
| Total liab | 3.50M | 1.17M | 0.68M | 6.08M | 0.15M |
| Total stockholder equity | 285.42M | 303.32M | 294.12M | 295.20M | 183.16M |
| Other current liab | -0.34M | -0.47M | - | - | - |
| Common stock | 1.81M | 1.81M | 1.81M | 1.81M | 1.41M |
| Capital stock | 1.81M | 1.81M | 1.81M | 1.81M | 1.41M |
| Retained earnings | - | -19.78M | - | - | 129.61M |
| Other assets | - | 304.49M | 0.59M | 0.75M | 0.14M |
| Cash | 32.26M | 38.51M | 40.02M | 31.33M | 27.43M |
| Total current liabilities | - | 0.23M | - | - | 8.60M |
| Net debt | -31.92M | -38.03M | -39.34M | -30.54M | -27.29M |
| Short term debt | 0.34M | 0.47M | - | - | - |
| Short long term debt total | 0.34M | 0.47M | 0.68M | 0.78M | 0.15M |
| Other stockholder equity | 283.61M | 301.51M | 292.31M | 293.39M | 181.76M |
| Property plant equipment | - | - | - | - | 0.01M |
| Total current assets | 32.47M | 38.75M | 40.57M | 31.72M | 27.48M |
| Long term investments | 256.00M | 265.08M | 254.29M | 268.81M | 164.13M |
| Net receivables | 0.22M | 0.24M | 0.56M | 0.39M | 0.05M |
| Accumulated other comprehensive income | - | 215.90M | - | - | - |
| Common stock total equity | - | - | - | - | 1.41M |
| Non currrent assets other | 256.29M | 265.52M | -254.59M | -268.82M | -164.13M |
| Non current assets total | 256.44M | 265.74M | 254.59M | 268.82M | 164.13M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total cashflows from investing activities | 0.93M | 6.81M | - | - | - |
| Total cash from financing activities | -2.79M | -5.15M | -5.43M | 52.73M | 27.69M |
| Net income | -15.22M | 13.80M | 59.31M | 59.31M | 19.68M |
| Change in cash | -6.25M | -1.51M | 8.69M | 3.89M | 12.32M |
| Begin period cash flow | 38.51M | 40.02M | 31.33M | 27.43M | 15.11M |
| End period cash flow | 32.26M | 38.51M | 40.02M | 31.33M | 27.43M |
| Total cash from operating activities | -4.38M | -3.17M | - | - | -15.37M |
| Issuance of capital stock | - | - | 0.00M | 55.00M | 28.29M |
| Depreciation | 0.15M | 0.15M | - | - | - |
| Sale purchase of stock | -2.79M | -5.15M | -5.43M | -0.91M | -0.05M |
| Other cashflows from financing activities | - | 6.81M | -1.36M | -1.36M | -0.55M |
| Capital expenditures | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M |
| Change in working capital | - | - | - | - | -15.37M |
| Other non cash items | 10.69M | -16.97M | -59.31M | -59.31M | -19.68M |
| Free cash flow | -4.39M | -3.17M | 14.12M | -48.83M | -15.37M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| MNTN Schiehallion Fund Ltd |
-0.01 0.46% |
2.18 | 0.05 | - | 4.35 | 1.25 | 5.65 |
| BHMU BH Macro Limited |
- -% |
4.29 | 0.09 | - | 39.01 | 0.71 | 6.47 |
| TFG Tetragon Financial Group Ltd |
0.15 1.00% |
15.10 | 0.02 | 7.04 | 1.16 | 0.31 | 2.06 |
| BPCR BioPharma Credit PLC |
0.00 0.41% |
0.98 | 0.09 | - | 6.73 | 0.91 | 7.95 |
Augmentum Fintech PLC is a venture capital fund specializing in seed, early to mid to late venture, series A & B investments. The firm does not invest in seed stage. The fund invests in unquoted fintech businesses which are high growth, with scalable opportunities, and have disruptive technologies in the banking, insurance and asset management sectors, including other cross-industry propositions. The fund focuses to invest in United Kingdom, Germany, France and the Nordics. The fund typically invests in firms with £4 million ($5.54 million) to £15 million ($20.80 million) equity investments. The fund prefers a significant minority stake in companies. The fund's objective is to make long term investments. The fund prefers to exit by the way of an IPO, with valuation return targets ranging from $61.46 million to in excess of $1,229.15 million.
25 Southampton Buildings, London, United Kingdom, WC2A 1AL
44 20 3961 5420
| Name | Title | Year Born |
|---|---|---|
| Mr. Tim Levene | CEO, Partner & Portfolio Mang. | NA |
| Mr. Perry Rael Blacher | Partner | 1974 |
| Mr. Richard Matthews | Partner & COO | NA |
| Mr. Nigel Szembel | IR Leader | NA |
| Mr. Martyn Holman | Venture Partner | NA |
| Mr. Réginald de Wasseige | Investor | NA |
| Ms. Ellen Logan | Investment Professional | NA |
| Ms. Georgie Hazell Kivell | Investment Professional | NA |
| Ms. Sarah Angeloz | Portfolio Analyst | NA |
| Mr. Johnnie Martin | Investor & Investment Analyst | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.